General Electric (NYSE: GE) has completed the first part of its breakup, and GE shareholders are now owners of GE HealthCare Technologies (NASDAQ: GEHC). But what should you make of the change, and are the shares worth selling, adding to, or initiating a new position in? Here's the lowdown. 

In a nutshell, it's an imaging and ultrasound equipment company. It's an attractive market to be in, given that an aging population in the developed world needs more scans and diagnoses. Meanwhile, improving healthcare standards in the developing world is also a demand driver. 

The company's full-year 2021 segment metrics are shown below. Patient care solutions include patient monitoring systems, anesthesia care, diagnostic cardiology, and maternal-infant care equipment. The high-margin pharmaceutical diagnostics business is exciting. GE HealthCare is the only imaging equipment provider to offer diagnostics (injectable agents and radioactive tracers) that improve scans and procedures. 

Continue reading

Source Fool.com